Ascend Learning Clinical Healthcare and QURE Healthcare form training development partnership and launch primary care physician modules designed to improve CDC safe opioid prescribing guideline compliance

LEAWOOD, Kan.Dec. 19, 2019 /PRNewswire/ — Ascend Learning Clinical Healthcare and QURE Healthcare have formed a partnership to reduce unneeded clinical variation and help practicing physicians make more evidence-based clinical decisions for their patients.

The first offering in this partnership, focused on primary care physicians, addresses the gap between Centers for Disease Control (CDC) Guidelines for Prescribing Opioids for Chronic Pain and actual practice among busy clinicians – an area of immense need across the country. In the recently completed QURE and Ascend nation-wide validation study, practicing primary care physicians demonstrated strong improvement across several key clinical decision-making areas, including overall evidence-based care decisions and diagnoses.

The six-week training program incorporated Ascend’s Insight to Action™ modules and leveraged QURE’s validated patient simulation-based training and feedback tool, known as Clinical Performance and Value (CPV) vignettes. The impact of the CPV intervention was determined using a psychometrically constructed pre-and post-assessment survey. The validation study initially assessed primary care provider knowledge of the evidence-based criteria in the CDC’s opioid guidelines. The physicians then went through a series of short, interactive, practice-focused clinical vignettes, wherein they are given real-time performance feedback on their care decisions. The providers could see how their care compared to the guidelines and compete with their peers for the top evidence-based scores. After the case-based training, they were assessed once more on their familiarity with latest guidelines.

After six weeks participants were:

  • 20% more likely to make evidence-based care decisions in the cases
  • 24% more likely to get the right diagnosis.
  • 2x more likely to appropriately wean patients from opioids.
  • Nearly 2x more likely to appropriately order naloxone for patients at high risk of opioid overdose (a rapid opioid-reversal nasal spray that can revive near-death patients, naloxone is under-prescribed and underutilized across the country).

The practicing physicians also rated their experience as tremendously positive, with a net promoter score of 57. In addition, 89% said they would like more of these modules in their practice and 88% indicated they planned to do something different in their clinical care based on the feedback they received.

“Physicians want to provide the best care to their patients, but often struggle to keep their clinical skills commensurate with the latest guidelines. The CDC opioid training illustrates just one example of where we have clear evidence-based clinical guidelines that are not followed consistently, which leads to variation in care, higher costs and less than optimal outcomes,” QURE President, John Peabody, MD, PhD, said. “Based on decades of research our group has published, we know that engaging, case-based scenarios combined with customized feedback make a real difference in clinical practice patterns. We are pleased to show in this validation study the impact this can have on an area of such importance to patients across the country.”

Dr. Peabody added, “Additionally, the modest time commitment of 10 minutes per case combined with the high level of physician satisfaction and engagement shows that this is an approach that can be easily rolled out and scaled at practices and health systems.”

“Ascend and QURE share a goal of addressing areas of unwarranted clinical care variation,” Nathan Walts, Ascend Learning Clinical Healthcare vice president of product strategy, provider market said. “Using the CDC guidelines as a test case and combining Ascend’s psychometrically valid assessments and QURE’s proven clinical vignette approach, we’re very encouraged by both the provider reaction and the clear difference in pre- and post-training treatment decisions and incremental improvement in case progression performance.”

SOURCE Ascend Learning Clinical Healthcare

Participating healthcare providers find Insight to Action™ training on CDC opioid prescribing guidelines enhances skills, effectively addresses professional education needs

LEAWOOD, Kan.Dec. 10, 2019 /PRNewswire/ — Ascend Learning Clinical Healthcare today announced key findings from its recent Insight to Action™ healthcare provider training pilot addressing the Centers for Disease Control (CDC) guidelines for safe opioid prescribing.

The pilot, open to physicians and other providers around the country, was designed to assess their knowledge of the guidelines and build skills where needed. Specific focus was around initiating difficult conversations with patients related to opioid use, and enhancing knowledge of the medications used to treat opioid use disorder.

Among the key findings of participating providers:

  • 85% felt the content was useful in their practice and 80% stated the assessment and training addressed a professional need.
  • 85% believed the training will enhance their knowledge/skill as a provider.
  • 84% believed the training helped reject outdated and moralistic beliefs about “addicts,” and “addiction.”
  • 81% cited a better recognition of those with opioid use disorder as patients in need of help.
  • 77% indicated the information learned will prompt behavioral changes in their practices.

The Insight to Action program is designed specifically for busy providers, addressing discrete clinical areas with intuitive simulation-based modules that take just under two hours to complete. An up-front baseline assessment helps providers understand their level of knowledge and proficiency, and provides targeted remediation when needed. It also provides system-level reports for administrators to better gauge overall guideline comprehension and compliance among their providers.

“We know that the CDC’s clinical guidelines, when followed, can help reduce the incidence and severity of opioid abuse,” said Nathan Walts, Vice President, Product Strategy, Ascend Learning Clinical Healthcare. “Unfortunately, that’s just one area where many providers don’t feel current on evidence-based guidelines. That leads to incomplete and inconsistent adoption of the guidelines, which hinders the care they deliver and results in higher costs.

“Insight to Action is designed to specifically address those areas of care variation. Based on our recruited sample, there is a high percentage of participants providing positive feedback and saying the modules help them. We’re encouraged by those positive responses and the benefits providers feel it will bring their practices and patients.”

Learn more about Insight to Action at https://ascendclinicalhealthcare.com/.

SOURCE Ascend Learning Clinical Healthcare

MedHub gives back

Recently, the MedHub group based in Minneapolis packaged food that will be distributed to children in Nicaragua with the non-profit Feed My Starving Children.    FMSC sends food to people in developing nations all over the world.   The food is specifically designed to assist in reversing and preventing undernutrition.   Together with other volunteers, the group packed 153 boxes, which is 33,048 meals – this will feed 91 children for a year.    With food, the children are able to thrive, go to school, and not worry about where their next meal will come from.   It was a fun and rewarding way to spend the afternoon with coworkers!